semaglutide approved for obesity fda oral approves type 2 diabetes, indication pending Semaglutide (Wegovy) for the Treatment

both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN-2

While Ozempics promotional campaigns touted its weight loss benefits, warnings about side effects, specifically severe gastrointestinal conditions like gastroparesis, were notably absent

Here is how to manage every common side effect during the tirzepatide to semaglutide switch

While most evidence doesnt suggest dramatic loss of muscle or bone from GLP-1s alone, keeping tabs on strength, mass, and nutritional status can help ensure your body composition and overall wellness remain supported long-term

I spend time in online GLP-1 communities, and users often share experiences of being shamed by comments implying theyre cheating. We would never say that to someone taking medication for diabetes or cholesterol, but weight loss is treated very differently